Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Small Diagnostic Firms Under Microscope As Gene Focus Rises
Jun 17, 2008 03:25 PM
- Is it time for Laboratory Corp to Pop?
May 01, 2008 11:32 AM
- Trading Ideas: These stocks Are looking very strong
Apr 30, 2008 11:34 AM
- Watch these stocks closely: LH, BAM
Apr 23, 2008 11:59 AM
- SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT
Apr 23, 2008 10:29 AM
- Target Lowered on Hold-Rated LH
Sep 07, 2007 04:09 PM
- Laboratory Corp (NYSE:LH): Jefferies calling for a bounce
Aug 02, 2007 09:43 AM
- LH: Lab Corp Margins Below Expectations
Jul 24, 2007 11:33 AM
- Esoterix Expands Exclusive Testing Rights for SHOX Gene Testing and Genentech Announces Preliminary Results from Randomized Phase II Trial of Avastin & Tarceva
Oct 19, 2005 10:01 AM
- Lockerbie & Hole Announces Project Delay
Nov 19, 2008 08:17 PM
- LabCorp Launches Tumor MGMT Gene Methylation Testing
Nov 19, 2008 07:02 AM
- Lockerbie & Hole Reports Purchases Under Normal Course Issuer Bid
Nov 12, 2008 02:02 PM
- LabCorp is Scheduled to Present at the Credit Suisse 2008 Global Healthcare Conference
Nov 07, 2008 07:02 AM
- LabCorp to be the First National Commercial Lab to Offer Roche's COBAS(R) TaqMan(R) HBV Test
Nov 06, 2008 04:37 PM
- Mubadala Healthcare and Laboratory Corporation of America Holdings Agree to Establish a National Reference Laboratory in Abu Dhabi
Nov 04, 2008 04:03 PM
- Seven Summits Research Releases Alerts on HD, AMGN, NUE, FDX, and LH
Oct 28, 2008 09:31 AM
- Investment Industry Regulatory Organization of Canada - Trade Resumption - Lockerbie & Hole Inc. - LH
Oct 24, 2008 01:48 PM
- Lockerbie & Hole Announces Project Delay
Oct 24, 2008 01:40 PM
- Investment Industry Regulatory Organization of Canada - Trading Halt - Lockerbie & Hole - LH
Oct 24, 2008 01:36 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
LH
|
Compare to S&P
|
| YTD |
-20.08 %
|
43.85 %
|
| 4 Weeks |
3.21 %
|
14.76 %
|
| 12 Weeks |
-17.39 %
|
31.26 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -8.87 %
|
|
EPS Growth in Last Year: 5.61 %
|
|
Sales Growth in Last Quarter: -1.11 %
|
|
Sales Growth in Last Quarter: 11.22 %
|
|
|
